Sasich, L. D., & Sukkari, S. R. (2011). The US FDAs withdrawal of the breast cancer indication for Avastin (bevacizumab).
Chicago Style CitationSasich, Larry D., i Sana Rikabi Sukkari. The US FDAs Withdrawal of the Breast Cancer Indication for Avastin (bevacizumab). 2011.
Cita MLASasich, Larry D., i Sana Rikabi Sukkari. The US FDAs Withdrawal of the Breast Cancer Indication for Avastin (bevacizumab). 2011.
Atenció: Aquestes cites poden no estar 100% correctes.